Patent details

Basic Information

Publication number:

EP2906252

PCT Application Number:

EP2013071343

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137886917

PCT Publication Number:

WO2014057115

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRROLOBENZODIAZEPINE-ANTI-HER2 ANTIBODY CONJUGATES

French Title of Invention:

CONJUGUÉS ANTICORPS ANTI-HER2 - PYRROLOBENZODIAZÉPINE

German Title of Invention:

PYRROLOBENZODIAZEPIN-ANTI-HER2-ANTIKÖRPERKONJUGATE

SPC Number:

Dates

Filing date:

11/10/2013

Grant date:

14/06/2017

EP Publication Date:

19/08/2015

PCT Publication Date:

17/04/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/06/2017

EP B1 Publication Date:

14/06/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/10/2018

Expiration date:

11/10/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/06/2017

 

 

Name:

ADC Therapeutics SA

Address:

Route de la Corniche 3B, 1066 Epalinges, Switzerland (CH)

Name:

Medimmune Limited

Address:

Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, United Kingdom (GB)

Agent

Name:

Office FREYLINGER S.A.

From:

16/08/2017

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

HOWARD, Philip Wilson

Address:

United Kingdom (GB)

2

Name:

VAN BERKEL, Patricius Hendrikus Cornelis

Address:

Switzerland (CH)

Priority

1

Priority Number:

201261712928 P

Priority Date:

12/10/2012

Priority Country:

United States (US)

2

Priority Number:

201261712924 P

Priority Date:

12/10/2012

Priority Country:

United States (US)

3

Priority Number:

201361784249 P

Priority Date:

14/03/2013

Priority Country:

United States (US)

4

Priority Number:

201361784233 P

Priority Date:

14/03/2013

Priority Country:

United States (US)

5

Priority Number:

201361784270 P

Priority Date:

14/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/551; A61K 39/395; A61P 35/00; C07K 16/32; A61K 47/68;

Publication

European Patent Bulletin

Issue number:

201724

Publication date:

14/06/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/10/2017

Last Annual Fee Paid Number:

5

Last Annual Fee Paid Amount:

52 Euro

Payer:

MEWBURN & ELLIS LLP

Filing date	Document type	Number of pages
28/02/2019	Outgoing Correspondence	1
22/08/2017	Outgoing Correspondence	1
16/08/2017	Power Of Attorney	1